or
forgot password

    • cancer clinical trials in boston, MA

    • Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
    Children's Hospital of Boston (Pediatric Site)
    Boston, Massachusetts 02115
    Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis
    Study of REN-1654 in Patients With Sciatica Pain
    Brigham & Women's Hospital, Pain Trials Center
    Boston, Massachusetts 02115
    Sciatica, Herniated Disc, Radiculopathy
    Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Boston University Cancer Research Center
    Boston, Massachusetts 02118
    Lung Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Tufts Medical Center
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Lymphoma
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Dana-Farber/Brigham and Women's Cancer Center
    Multiple Myeloma and Plasma Cell Neoplasm
    Scleroderma: Cyclophosphamide or Transplantation (SCOT)
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Scleroderma, Systemic, Sclerosis, Autoimmune Disease
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Dana-Farber/Brigham and Women's Cancer Center
    Breast Cancer
    Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Mantle Cell Lymphoma
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Dana Faber Cancer Institute
    Boston, Massachusetts 02115
    Myeloid Leukemia, Chronic, Chronic-Phase
    Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
    Dana Faber Cancer Institute
    Boston, Massachusetts 02115
    Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Massachusetts General Hospital
    Liver Cancer
    A Study in Adults With Untreated Acute Lymphoblastic Leukemia
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Acute Lymphoblastic Leukemia
    Avastin and Taxotere for Esophagogastric Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Esophageal Cancer, Gastric Cancer
    Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Adenocarcinoma, Non-small Cell Lung Cancer
    Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Esophageal Cancer
    Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Hepatocellular Carcinoma
    Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Biliary Tract Cancer, Gallbladder Adenocarcinoma
    Therapy for Pediatric Hodgkin Lymphoma
    Massachusetts General Hospital

    Trial Locations
    Massachusetts General Hospital
    Dana Farber Cancer Institute
    Hodgkin Lymphoma
    Preoperative Herceptin and Navelbine for Breast Cancer
    Massachusetts General Hospital

    Trial Locations
    Massachusetts General Hospital
    Dana-Farber Cancer Center
    Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer
    Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
    Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Non-Hodgkin's Lymphoma
    Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors
    Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Breast Cancer
    Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Center
    Refractory Multiple Myeloma, Relapsed Multiple Myeloma, Multiple Myeloma
    Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
    Massachusetts General Hospital

    Trial Locations
    Massachusetts General Hospital
    Dana-Farber Cancer Center
    Duct Carcinoma in Situ of the Breast
    Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Hodgkin's Disease